Phoebe Stratton
Phoebe Stratton writes for Fyla Digest and other Independent Journal publications, covering SEC filings and securities regulation and IPOs, direct listings and exchange listings. Reporting under this byline is prepared by the Independent Journal editorial desk from primary sources, with AI assistance, and reviewed under our editorial policy.
5 articles
BKV Corp 8-K Filing Flags a Material Agreement
BKV Corp filed an 8-K on Oct. 7 citing Items 1.01, 7.01 and 9.01. Here is what those items mean, what is still unknown and what to watch in the full text.
Insmed 8-K filing: officer change and Reg FD items explained
Insmed filed an 8-K on Oct. 5, 2026 with Items 5.02, 7.01 and 9.01. Here is what those items mean, what the feed does not say, and what to check next.
Lixiang Education F-1 Filing Registers ADSs Tied to a Planned $12.5M Share Sale
Lixiang Education's F-1 filing of September 11, 2026 registers ADS resales tied to a $10 million subscription, and shows the CEO reaching 97% of the vote.
Aggreko's F-1 Filing Targets an NYSE Listing Under AGKO
Aggreko Inc. filed an F-1 on Aug. 24, 2026 to list on the NYSE as AGKO, reporting $3.4 billion in revenue and a $113 million net loss for its latest year.
Lime Parent Neutron Holdings Makes Its S-1 Filing for Nasdaq
Neutron Holdings, parent of Lime, filed an S-1 on May 8, 2026 to list as LIME. The filing shows $886.7M in 2025 revenue and plans to repay its term loan.